新型前列腺癌療法在不犧牲療效的前提下大幅減少副作用！

A major study in the UK has found that a targeted treatment for prostate cancer, called focal therapy, can be just as effective as traditional surgery or radiotherapy but with fewer side effects. Prostate cancer is the most common cancer in men in the UK, with over 64,000 men diagnosed each year. Many men worry about the side effects of treatment, such as incontinence or loss of sexual function. Focal therapy is a less invasive treatment that uses high-intensity ultrasound or freezing to destroy only the cancerous parts of the prostate, leaving the rest of the gland untouched.

Researchers at Imperial College London followed nearly 3,500 men who received focal therapy for ten years. The results were impressive: only two men died from prostate cancer during that time, which is similar to the results seen with surgery or radiotherapy. However, men who had focal therapy were much less likely to experience side effects. In fact, the risk of problems like urine leakage or sexual difficulties was less than half compared to other treatments. This is important because these side effects can have a big impact on a man's quality of life.

Despite being available for over 20 years, focal therapy is not widely used in the UK. Only about 1,000 men receive it each year, even though up to 15,000 could benefit. One reason is that health regulators wanted to see more long-term evidence before recommending it as a routine treatment. This new study provides that evidence, and experts hope it will lead to more hospitals offering focal therapy. The government has recently promised more funding to expand access to this treatment. Some men, like Rob Huxford and Paul Sayer, have shared their positive experiences with focal therapy and believe it should be available to all men who need it. The study could also help pave the way for a national screening program for prostate cancer, which could save even more lives in the future.